Patents expiring in 2036

US 9328140

Modified mini-hepcidin peptides and methods of using thereof

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326975

Substituted pyrazolone compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326991

Nucleotide prodrug compounds and use

Ligand Pharmaceuticals Incorporated · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328129

Peptidomimetic inhibitors of PSMA

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326978

A3 adenosine receptor allosteric modulators

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326950

Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326992

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9327028

Acetylcysteine compositions and methods of use thereof

Cumberland Pharmaceuticals Inc. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9326995

Oxides for wound healing and body repair

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328142

Lipopeptide inhibitors of RAS oncoproteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9327016

Enzymes and methods for cleaving N-glycans from glycoproteins

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328148

Campylobacter immunogenic compositions and uses thereof

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328200

Branched polymeric quaternary ammonium compounds and their uses

ULTRASCI DISCOVERY LLP · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9327036

DNA-cell conjugates

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328391

Cloning and expression of HIV-1 DNA

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9327258

Porous silica-based particles having smooth surface, method for production thereof and cosmetic comprising such particles

JGC Catalysts and Chemicals Ltd. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328339

Modified factor IX polypeptides and uses thereof

Catalyst Biosciences, Inc. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328077

Bicyclic PKM2 activators

Agios Pharmaceuticals, Inc. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328324

System, method and devices for tissue-based diagnosis

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9328387

Antipsychotic treatment based on SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3013366

KOMBINATIONSTHERAPIE MIT EINEM FAKTOR XII-HEMMER UND EINEM C1-HEMMER

CSL BEHRING GMBH [DE] · Granted Wed May 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Apr 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333245

Methods and compositions for treating wounds and reducing the risk of incisional hernias

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334245

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333258

Fine spatiotemporal control of fat removal using NIR light

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334522

Agents and methods to elicit anti-tumor immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333171

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333248

Methods and composition related to Th-1 dendritic cells

The Board of Regents of the University of Texas System · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333148

Polymerizable composition and dental material

KURARAY NORITAKE DENTAL INC. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333195

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333244

Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia

HALOZYME, INC. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333237

Bone morphogenic protein binding peptide

The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333251

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333200

Multi-arm polymer prodrugs

Nektar Therapeutics · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333259

Selective fat removal using NIR light and nanoparticles

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333267

Thiol-selective water-soluble polymer derivatives

Nektar Therapeutics · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334244

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334235

Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging

Phenomenome Discoveries Inc. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334306

Leukemia stem cell targeting ligands and methods of use

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9333264

Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334364

Methods for preparing polymeric reagents and compositions of polymeric reagents

Nektar Therapeutics · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334246

Substituted triazines for malaria treatment and chemoprophylaxis

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334250

Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9334495

Minor groove binder (MGB)-oligonucleotide miRNA antagonists

ELITECHGROUP B.V. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2016128999

MASITINIB FOR TREATING HEPATIC CANCER

AB SCIENCE [FR] · Granted Thu May 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2016071511

TRAITEMENT DU SYNDROME D'ACTIVATION MASTOCYTAIRE (SAMA) AVEC LE MASINITIB

AB SCIENCE [FR] · Granted Thu May 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9339433

Methods of diagnosing and treating neonatal reversion to fetal consciousness

The Regents of the University of California · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9339491

Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease

MEREO BIOPHARMA 1 LIMITED · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9339469

R(+)-N-methyl-propargyl-aminoindan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)